Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era

Nicola Squillace,1 Giorgio Bozzi,2 Elisa Colella,1 Andrea Gori,2 Alessandra Bandera1 1Infectious Diseases Unit, Azienda Socio Sanitaria Territoriale di Monza, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy; 2Infectious Disease Unit, Department of Internal Medicine, Fondazione IRCC...

Full description

Bibliographic Details

Published in:	Drug Design, Development and Therapy
Main Authors:	Squillace N, Bozzi G, Colella E, Gori A, Bandera A
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Subjects:	Protease inhibitors darunavir/cobicistat emtricitabine/tenofovir alafenamide HIV
Online Access:	https://www.dovepress.com/darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-safety-and-ef-peer-reviewed-article-DDDT